The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center is a clinical research site located in Columbus, Ohio, United States 43210.
Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center has participated in 7 clinical trials with 6 currently active.
Therapeutic areas: GIST, Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors, Head and Neck Squamous Cell Carcinoma (HNSCC).
Sponsors: Deciphera Pharmaceuticals, LLC, Cogent Biosciences, Inc., Tanabe Pharma America, Inc..
Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center has 7 clinical trials on record, with 6 currently active. Their work covers GIST, Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors, Head and Neck Squamous Cell Carcinoma (HNSCC).
Yes — The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.